TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ALEC

Alector Inc

Healthcare · Biotechnology

1.90$ +3.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ALEC
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
3,287.0% 800.8% 263.9% 473.8% 743.5% 91.5% 6.3% 9.1% 184.9% 45.9%
-3,187.0% -700.8% 100.0% 100.0% 100.0% 100.0% 100.0% 90.9% -84.9% 54.1%
3,287.0% 800.8% 263.9% 473.8% 743.5% 91.5% 157.5% 197.9% 208.1% 584.8%
450.5% 174.1% 43.1% 165.4% 281.6% 26.6% 45.7% 58.4% 57.1% 256.5%
3,737.5% 974.9% 307.0% 639.2% 1,025.1% 118.0% 203.2% 247.2% 59.3% 746.9%
-3,637.5% -874.9% -207.0% -539.2% -925.1% -18.0% -103.2% -156.3% -144.2% -692.8%
0.0% 0.0% 0.0% 0.0% 0.0% 4.0% 12.2%
-3,632.2% -869.6% -188.8% -496.7% -901.6% -17.5% -97.3% -129.0% -118.3% -678.4%
0.0% 0.0% 18.2% -26.3% -34.4% -4.0% 2.4% 5.4% 0.1% 0.8%
-3,632.2% -869.6% -188.8% -470.4% -867.2% -13.5% -99.8% -134.3% -118.4% -679.2%
-3,589.2% -856.7% -203.3% -512.9% -890.6% -14.0% -96.8% -119.9% -109.5% -632.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?